Exploring Enrollment and Participation Patterns in Weight Loss Clinical Trials Patients: An Observational Clinical Trial Perspective

Power Life Sciences Inc.1 site in 1 country500 target enrollmentDecember 2024

ConditionsWeight Loss

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Weight Loss
Sponsor: Power Life Sciences Inc.
Enrollment: 500
Locations: 1
Primary Endpoint: Rate of patients who decide to enroll in a weight loss clinical study.
Status: Not yet recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Clinical studies, with a distinct focus on weight loss, play a crucial role in evaluating the safety and effectiveness of novel treatments. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption.

The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.

Registry

clinicaltrials.gov

Start Date

December 2024

End Date

December 2026

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Power Life Sciences Inc.

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Interested in losing weight and not enrolled in a formal weight loss program or taking medications or supplements that may cause weight change
•Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study.
•Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed

Exclusion Criteria

•Enrolled in another research study
•Inability to provide written informed consent
•Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial